Nadia Rosenthal

Nadia Rosenthal, Ph.D.

Born in the US, Professor Nadia Rosenthal obtained her PhD in 1981 from Harvard Medical School and trained as a postdoctoral fellow at NIH, then directed a biomedical research laboratory at Harvard Medical School, and served for a decade at the New England Journal of Medicine as editor of the Molecular Medicine series. In 2001 she moved to Rome to head the EMBL Mouse Biology Unit, and holds a Professorship of Cardiovascular Science at Imperial College London. She is an EMBO member, with numerous awards and honors including the Ferrari-Soave Prize in Cell Biology and a Doctor Honoris Causa from the Pierre and Marie Curie University in Paris. She serves on international grant review committees, advisory panels and editorial boards and coordinates several major EU consortia on mouse genetics and disease models. She recently spearheaded the election of Australia to EMBL as its first Associate Member, and founded the Australian Regenerative Medicine Institute at Monash University, which serves as Headquarters for the EMBL Australia Partner Laboratory Network. She is an NH&MRC Australia Fellow.

Rosenthal’s research has used mammalian genetics to explore the embryonic development of heart and skeletal muscle and the regeneration of adult tissues. In the last decade her focus on the biology of insulin-like growth factors has led to significant advances in novel cell-based therapies for muscle ageing and heart disease.